Latest Ratios: P/E Ratio 9.0x · EV/EBITDA 9.1x · ROE 14.8%. (2002–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.0B | $936M | $933M | $467M | $528M | $440M | $341M | $447M | $393M | $394M | $420M |
| Enterprise Value | $1.5B | $1.4B | $1.3B | $967M | $1.2B | $913M | $563M | $514M | $515M | $435M | $440M |
| P/E Ratio → | 9.00 | 8.04 | 26.65 | 20.83 | 12.00 | 12.17 | 12.89 | 26.37 | 17.73 | 18.94 | 20.43 |
| P/S Ratio | 2.13 | 1.91 | 2.35 | 2.88 | 4.14 | 3.69 | 2.81 | 3.51 | 5.38 | 6.27 | 6.71 |
| P/B Ratio | 1.23 | 1.10 | 1.28 | 1.48 | 1.93 | 1.13 | 0.89 | 1.27 | 2.85 | 3.05 | 3.52 |
| P/FCF | 10.89 | 9.73 | 11.49 | 16.54 | 13.90 | 8.17 | 16.66 | 18.71 | 18.99 | 18.94 | — |
| P/OCF | 9.71 | 8.68 | 10.84 | 10.99 | 8.65 | 8.01 | 14.72 | 17.41 | 16.79 | 16.62 | 10523.67 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.89 | 3.21 | 5.96 | 9.13 | 7.66 | 4.64 | 4.03 | 7.06 | 6.92 | 7.03 |
| EV / EBITDA | 9.14 | 8.47 | 22.25 | 34.61 | 21.03 | 20.91 | 17.93 | 25.98 | 14.13 | 13.05 | 13.47 |
| EV / EBIT | 10.57 | 9.80 | 31.96 | 38.58 | 22.25 | 22.57 | 19.78 | 30.71 | 15.59 | 14.15 | 14.14 |
| EV / FCF | — | 14.76 | 15.70 | 34.21 | 30.64 | 16.94 | 27.46 | 21.48 | 24.91 | 20.92 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | 58.5% | 67.1% | 98.8% | 97.3% | 80.3% | 78.3% | 81.7% | 87.6% | 85.4% |
| Operating Margin | 29.5% | 29.5% | 10.1% | 15.4% | 41.0% | 33.9% | 23.4% | 13.1% | 45.3% | 49.0% | 49.7% |
| Net Profit Margin | 23.9% | 23.9% | 9.0% | 14.0% | 34.5% | 30.4% | 21.8% | 13.3% | 30.3% | 33.1% | 32.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 14.8% | 14.8% | 6.8% | 7.7% | 13.3% | 9.3% | 7.2% | 4.8% | 16.6% | 16.7% | 17.7% |
| ROA | 1.5% | 1.5% | 0.6% | 0.6% | 1.2% | 1.0% | 0.8% | 0.6% | 1.6% | 1.7% | 1.8% |
| ROIC | 8.4% | 8.4% | 2.9% | 2.1% | 4.1% | 3.4% | 3.2% | 2.5% | 10.3% | 12.7% | 14.9% |
| ROCE | 3.5% | 3.5% | 6.4% | 8.5% | 15.8% | 10.4% | 7.7% | 4.7% | 25.4% | 25.3% | 27.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.63 | 0.63 | 0.65 | 1.73 | 2.51 | 1.41 | 1.17 | 0.42 | 1.08 | 0.52 | 0.40 |
| Debt / EBITDA | 3.21 | 3.21 | 8.32 | 19.48 | 12.40 | 12.60 | 14.34 | 7.59 | 4.08 | 2.00 | 1.46 |
| Net Debt / Equity | — | 0.57 | 0.47 | 1.59 | 2.33 | 1.21 | 0.57 | 0.19 | 0.89 | 0.32 | 0.17 |
| Net Debt / EBITDA | 2.89 | 2.89 | 5.96 | 17.88 | 11.49 | 10.83 | 7.05 | 3.35 | 3.35 | 1.23 | 0.61 |
| Debt / FCF | — | 5.03 | 4.20 | 17.68 | 16.74 | 8.77 | 10.80 | 2.77 | 5.91 | 1.98 | — |
| Interest Coverage | 0.97 | 0.97 | 0.28 | 0.47 | 5.85 | 9.59 | 2.52 | 0.78 | 2.61 | 4.02 | 3.46 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.79 | 3.79 | 0.07 | 0.17 | 0.44 | 0.53 | 0.46 | 0.31 | 0.03 | 0.03 | 0.03 |
| Quick Ratio | 3.79 | 3.79 | 0.07 | 0.17 | 0.44 | 0.53 | 0.46 | 0.31 | 0.03 | 0.03 | 0.03 |
| Cash Ratio | 0.12 | 0.12 | 0.02 | 0.01 | 0.02 | 0.02 | 0.08 | 0.03 | 0.02 | 0.02 | 0.03 |
| Asset Turnover | — | 0.06 | 0.05 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.2% | 3.6% | 3.1% | 3.4% | 3.0% | 3.4% | 4.4% | 3.4% | 2.2% | 2.0% | 1.7% |
| Payout Ratio | 28.9% | 28.9% | 80.2% | 69.4% | 35.8% | 41.1% | 56.2% | 88.3% | 39.9% | 38.8% | 34.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 11.1% | 12.4% | 3.8% | 4.8% | 8.3% | 8.2% | 7.8% | 3.8% | 5.6% | 5.3% | 4.9% |
| FCF Yield | 9.2% | 10.3% | 8.7% | 6.0% | 7.2% | 12.2% | 6.0% | 5.3% | 5.3% | 5.3% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.5% | 0.7% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.2% | 3.6% | 3.1% | 3.4% | 3.0% | 3.6% | 4.8% | 4.0% | 2.2% | 2.0% | 1.7% |
| Shares Outstanding | — | $15M | $15M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M |
CRE Concentration and Integration
Based on recent market data, BHRB trades at a P/B of 1.25, which, when compared to the peer group average, suggests investors are applying a discount to account for the execution risks inherent in the recent Summit Financial Group merger and the resulting balance sheet complexity.
The current valuation multiple appears to reflect a market waiting for evidence of sustained earnings power rather than just asset scale. Given the bank's transition to a Nasdaq listing, the current P/B ratio warrants further investigation to determine if the market is correctly pricing the potential for improved ROTCE as the integration matures.
As reported in financial statements, BHRB's ROE has remained constrained at 3.2% in 2026Q1, a figure that underscores the difficulty of generating meaningful returns on equity while the bank navigates the integration of a significantly larger and more disparate asset base following its recent merger.
The DuPont decomposition suggests that profitability is currently hampered by a combination of compressed NIM and the absorption of merger-related costs. Investors should monitor whether the bank can improve its asset utilization and non-interest income contribution to drive ROE closer to historical norms as the operational footprint stabilizes.
According to quarterly filings, BHRB has maintained a stagnant NIM of 0.9% over the last four quarters, indicating that the bank's asset yields are struggling to outpace the rising cost of deposits in the highly competitive Northern Virginia and Mid-Atlantic banking markets.
The efficiency ratio of 43.4% in 2026Q1 suggests that while cost control remains a focus, the bank is facing structural challenges in maintaining operating leverage. This trend warrants further investigation into whether the bank's reliance on high-touch private banking services is creating a permanent drag on its ability to scale profitably.
Based on recent regulatory disclosures, BHRB has maintained an equity-to-assets ratio of 0.11 as of 2026Q1, demonstrating that management has successfully preserved capital buffers despite the significant balance sheet expansion and the operational complexities introduced by the recent Summit Financial Group merger.
While the current capital position appears adequate, the bank's elevated CRE concentration relative to regulatory guidelines may limit its flexibility for aggressive capital returns. Investors should monitor whether future capital allocation remains focused on organic growth or if the bank will prioritize strengthening its CET1 position to satisfy potential supervisory scrutiny.
The P/E ratio is frequently misapplied to BHRB, as it obscures the significant volatility in earnings caused by purchase accounting adjustments and CECL-related provision swings that do not reflect the bank's underlying cash-generating capacity or its long-term franchise value.
Analysts should instead prioritize P/TBV and ROTCE, as these metrics provide a clearer view of the bank's capital efficiency and the value of its tangible assets. Relying on P/E in the context of a recent transformative merger risks misinterpreting accounting noise as a fundamental shift in the bank's profitability profile.
Includes 30+ ratios · 11 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BHRB stock.
Burke & Herbert Financial Services Corp.'s current P/E ratio is 9.0x. The historical average is 17.6x. This places it at the 10th percentile of its historical range.
Burke & Herbert Financial Services Corp.'s current EV/EBITDA is 9.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 19.2x.
Burke & Herbert Financial Services Corp.'s return on equity (ROE) is 14.8%. The historical average is 12.0%.
Based on historical data, Burke & Herbert Financial Services Corp. is trading at a P/E of 9.0x. This is at the 10th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Burke & Herbert Financial Services Corp.'s current dividend yield is 3.24% with a payout ratio of 28.9%.
Burke & Herbert Financial Services Corp. has 69.3% gross margin and 29.5% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Burke & Herbert Financial Services Corp.'s Debt/EBITDA ratio is 3.2x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.